Membrane formation in the chamber angle after failure of argon laser trabeculoplasty: Analysis of risk factors

British Journal of Ophthalmology

Volumn 84, Issue 1, 2000, Pages 48-53

  Koller, T ^a   Sturmer J ^a   Reme Ch ^a   Gloor, B ^a  

^a UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGON;

AGED; ANTERIOR EYE CHAMBER ANGLE; ARGON LASER; ARTICLE; CONTROLLED STUDY; GLAUCOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEMBRANE FORMATION; MICROSCOPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TRABECULAR MESHWORK; TRABECULOPLASTY; TREATMENT FAILURE;

AGED; HUMANS; LASER SURGERY; MICROSCOPY, ELECTRON; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TRABECULAR MESHWORK; TRABECULECTOMY;

EID: 1642618111     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.1.48     Document Type: Article

References (46)

1. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma: a pilot study. J Glaucoma 1979;2:7-12.
2. Johnson DH, Yoshikawa K, Brubaker RF, et al. The effect of long-term medical therapy on the outcome of filtration surgery. Am J Ophthalmol 1994;117:139-48.
3. Ritch R, Liebmann J, Robin A, et al. Argon laser trabeculoplasty in pigmentary glaucoma. Ophthalmology 1993;100: 909-13.
4. Shingleton BJ, Richter CU, Dharma SK, et al. Long-term efficacy of argon laser trabeculoplasty. Ophthalmology 1993;100:1324-9.
5. Spaeth GL, Baez KA. Argon laser trabeculoplasty controls one third of cases of progressive, uncontroled open angle glaucoma for 5 years. Arch Ophthalmol 1992;110:491-4.
6. Federspiel E, Remé Ch, Gloor B, et al. Why do some argon-laser trabeculoplasties fail. Laser Ophthalmol 1987;14:191-6.
7. Alexander RA, Grierson I, Church WH. The effect of argon laser trabeculoplasty upon the normal human trabecular meshwork. Graefes Arch Clin Exp Ophthalmol 1989;227:72-7.
8. Alexander RA, Grierson I. Morphological effects of argon laser trabeculoplasty upon the glaucomatous meshwork. Eye 1989;3:719-26.
9. Stürmer J, Meier-Gibbons F, Clausen M, et al. Cell proliferation and membrane formation concomitant with extreme intraocular pressure increase following argon laser trabeculoplasty. Krieglstein GK (Hrsg) Glaucoma update Vol V, 1. Heidelberg: Aufl Kaden, 321-30.
10. Rodrigues MM, Spaeth GL, Donohoo P. Electron microscopy of argon laser therapy in phakic open-angle glaucoma. Ophthalmology 1982;26:1336-42.
11. De-Concini M, Boi S, Detassis C. Microscopical study of trabeculum after laser cyclotrabeculospasis: case report. Pathologica 1993;85:563-7.
12. Babizhayev MA, Brodskaya MW, Mamedov NG, et al. Clinical, structural and molecular phototherapy effects of laser irradiation on the trabecular meshwork of human glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol 1990; 228:90-100.
13. Melamed S, Pei J, Epstein DL. Short-term effect of argon laser trabeculoplasty in monkeys. Arch Ophthalmol 1985; 103:1546-52.
14. Melamed S, Pei J, Epstein DL. Delayed response to argon laser trabeculoplasty in monkeys. Morphological and morphometric analysis. Arch Ophthalmol 1986;104:1078-83.
15. Melamed S, Epstein DL. Alterations of aqueous humour outflow following argon laser trabeculoplasty in monkeys. Br J Ophthalmol 1987;71:776-81.
16. Koss MC, March WF, Nordquist RE, et al. Acute intraocular pressure elevation produced by argon laser trabeculoplasty in the cynomolgus monkey. Arch Ophthalmol 1984;102:1699-703.
17. Alvarado JA. Laser photocoagulation for glaucoma research and therapy. Arch Ophthalmol 1984;102:1604-16.
18. Bylsma SS, Samples JR, Van Buskirk EM. Trabecular cell division after argon laser trabeculoplasty. Arch Ophthalmol 1988;106:544-7.
19. Dueker DK, Norberg M, Johnson DH, et al. Stimulation of cell division by argon and Nd:YAG laser trabeculoplasty in cynomolgus monkeys. Invest Ophthalmol Vis Sci 1990;31: 115-24.
20. Herbort CP, Mermoud A, Schnyder C, et al. Antiinflammatory effect of topical diclofenac sodium (Voltarene Ophta) after argon laser trabeculoplasty: preliminary results of a prospective double-blind method. Klin Monatsbl Augenheilkd 1992;200:358-61.
21. Mermoud A, Pittet N, Herbert CP. Inflammation patterns after laser trabeculoplasty measured with the laser flare meter. Arch Ophthalmol 1992;110:368-70
22. Bergea B. Repeated argon laser trabeculoplasty. Acta Ophthalmol Copenh 1986;64:246-50.
23. Huk B, Garus HJ, Bleckmann H. Anti-inflammatory treatment after argon laser trabeculoplasty. Ophthalmologica 1991;203:24-9.
24. Hugkulstone CE. The effects of different energy levels in argon laser trabeculoplasty. Acta Ophthalmol Copenh 1989; 67:271-4.
25. Hugkulstone CE. Argon laser trabeculoplasty with standard and long duration. Acta Ophthalmol Copenh 1990;68:579-81.
26. Hugkulstone CE. Standard and long duration repeat argon laser trabeculoplasty. Acta Ophthalmol Copenh 1990;68: 575-8.
27. Bergea B. Intraocular pressure reduction after argon laser trabeculoplasty in open-angle glaucoma. A two-year follow-up. Acta Ophthalmol Copenh 1986;64:401-6.
28. Fink AI, Jordan AJ, Lao PN, et al. Therapeutic limitations of argon laser trabeculoplasty. Br J Ophthalmol 1988;72:263-9.
29. Rouhiainen H, Terasvirta M. The laser power needed for optimum results in argon laser trabeculoplasty. Acta Ophthalmol Copenh 1986;64:254-7.
30. Rouhiainen H, Terasvirta M, Tuovinen E. Low power argon laser trabeculoplasty. Acta Ophthalmol Copenh 1987;65:67-70.
31. Rouhiainen HJ, Terasvirta ME, Tuovinen EJ. Laser power and postoperative intraocular pressure increase in argon laser trabeculoplasty. Arch Ophthalmol 1987;105:1352-4.
32. Juhas T, Doci J. Complications of argon laser trabeculoplasty. Cesk Oftalmol 1989;45:111-21.
33. Juhas T. Argon laser trabeculoplasty. Methods, results and complications. Cesk Oftalmol 1990;46:106-15.
34. Weinreb RN, Ruderman J, Juster R, et al. Influence of the number of laser burns administered on the early results of argon laser trabeculoplasty. Am J Ophthalmol 1983;95:287-92.
35. Weinreb RN, Ruderman J, Juster R, et al. Immediate intraocular pressure response to argon laser trabeculoplasty. Am J Ophthalmol 1983;95:279-86.
36. Takenaka Y, Yamamoto T, Shirato S. One-quadrant argon laser trabeculoplasty and its indication. Jpn J Ophthalmol 1987;31:483-8.
37. Richter CU, Shingleton BJ, Bellows AR, et al. Retreatment with argon laser trabeculoplasty. Ophthalmology 1987;94: 1085-9.
38. Jorizzo PA, Samples JR, Van-Buskirk EM. The effect of repeat argon laser trabeculoplasty. Am J Ophthalmol 1988; 106:682-5.
39. Brown SV, Thomas JV, Simmons RJ. Laser trabeculoplasty re-treatment. Am J Ophthalmol 1985;99:8-10.
40. Schoenleber DB, Bellows AR, Hutchinson BT. Failed laser trabeculoplasty requiring surgery in open-angle glaucoma. Ophthalmic Surg 1987;18:796-9.
41. Feldman RM, Gross RL, Spaeth G, et al. Risk factors for the development of Tenon's capsule cysts after trabeculectomy. Ophthalmology 1989;96:336-11.
42. Hoskins HD Jr, Migliazzo C. Management of failing filtering blebs with the argon laser. Ophthalmic Surgery 1984;15:731-3.
43. Ophir A, Ticho U. Delayed filtering bleb encapsulation. Ophthalmic Surg 1992;23:38-9.
44. Ophir A. Encapsulated filtering bleb: a selective review -new deductions. Eye 1992;6:348-52.
45. Richter CU, Shingleton BJ, Bellows AR, et al. The development of encapsulated filtering blebs. Ophthalmology 1988; 959:1163-8.
46. Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 1994;101: 1651-7.